Action2012
Miasmata
Miasmata is an indie action and adventure game developed by IonFx and published by IonFX Studios, released on 28 November 2012 for Windows. Players most often tag it Survival, Exploration and Indie. Its 1,210 Steam reviews are 77% positive, which falls in Steam's Mostly Positive band. Its US list price is $14.99.
Miasmata is a first-person survival/adventure game, developed from the ground-up by brothers Joe and Bob Johnson. You play as Robert Hughes, a plague-stricken scientist on a journey to discover a cure. Your adventure begins on the shores of a remote and mysterious island.
Where it stands
Each bar shows the share of the catalogue this game outranks.
- Steam reviews1,210
More reviews than 95% of games on Steam. Ranked 152nd of 322 games released in 2012.
- Positive share77%
Higher than 41% of the 55,915 games with at least 10 reviews.
- Price$14.99
Costs more than 68% of paid games released in 2012. The median that year was $9.99.
- Peak players1
Higher than 0% of the 19,420 games with a recorded peak.
- Estimated owners100K to 200K
A higher owner band than 92% of games with an estimate.
One of 10 games released on Wednesday 28 November 2012. See every game from November 2012.
Details
- Developer
- IonFx
- Publisher
- IonFX Studios
- Release date
- Wednesday 28 November 2012
- Price
- $14.99 US list price
- Steam reviews
- 1,210 935 positive, 275 negative
- Rating band
- Mostly Positive from Steam thresholds
- Estimated owners
- 100,000 to 200,000 SteamSpy band
- Peak concurrent players
- 1 day before snapshot
- Metacritic score
- 76
- Achievements
- 27
- Platforms
- Windows
- Interface languages
- 1 English
- Content notes
- Gameplay mechanic involves ingesting improvised and fictitious medicines. Non-specific allusions to psychedelic drugs. Depictions of dead bodies with blood and bodily injury.
- Steam app ID
- 223510
Tags players use
Store features
- Single-player
- Steam Achievements
- Family Sharing
Games with similar tags
Matched on the community tags players apply most, weighted toward rarer tags, from other studios.